BWAY

Brainsway
BWAY
Market cap $233M

12.31 USD

-0.33

2.61%

At close Jul 11, 4:00 PM EDT

1 day

-2.61%

5 days

-9.68%

1 month

4.94%

3 months

45.51%

6 months

30.54%

Year to date

28.50%

1 year

91.45%

5 years

114.83%

10 years

11.00%

About: BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Employees: 120

Healthcare Medical Devices

0

Funds holding %

of 7,312 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

8% more funds holding

Funds holding: 39 [Q4 2024] → 42 (+3) [Q1 2025]

1% more capital invested

Capital invested by funds: $56.1M [Q4 2024] → $56.7M (+$557K) [Q1 2025]

0.05% more ownership

Funds ownership: 15.81% [Q4 2024] → 15.86% (+0.05%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$16

30%

upside

Avg. target

$16

30%

upside

High target

$16

30%

upside

1 analyst rating

1 positive

100%

0 neutral

0%

0 negative

0%

HC Wainwright & Co.

Raghuram Selvaraju

30%upside

$16

Buy

Reiterated

12 Jun 2025

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about BWAY published over the past 30 days

Zacks Investment Research

Is the Options Market Predicting a Spike in Brainsway Stock?

Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Brainsway Stock?

Zacks Investment Research

Wall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade

The mean of analysts' price targets for Brainsway (BWAY) points to a 31% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade

Zacks Investment Research

Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?

Brainsway (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?

Zacks Investment Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

Zacks Investment Research

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Improvement in depression scores, response and remission were all found to be comparable with standard Deep TMS in non-inferiority trial Improvement in depression scores, response and remission were all found to be comparable with standard Deep TMS in non-inferiority trial

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Zacks Investment Research

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

BURLINGTON, Mass. and JERUSALEM, June 10, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd.

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Zacks Investment Research

Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect?

The mean of analysts' price targets for Brainsway (BWAY) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect?

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to raise awareness and expand access to transformative care BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to raise awareness and expand access to transformative care

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

See News Rankings

Charts implemented using Lightweight Charts™